Methoxatone

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameMethoxatone

Drug Alias NameNafocare B美速胺Nafocare B1MFBLAC1L4MDL +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsBrain Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAllergan Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAllergan Plc

Active IndicationsN/A

Inactive IndicationsBrain Injuries

ATC CodeN/A